Innovating Works

HYPERION

Financiado
Proof of concept of affordable and scalable DNA data storage by developing a wri...
Proof of concept of affordable and scalable DNA data storage by developing a writing technology based on enzymatic DNA synthesis with a very dense semiconductor integrated circuit (CMOS chip The Hyperion project will prove the concept of affordable, scalable data storage with DNA by developing a world beating writing technology based on the precise, robust control of enzymatic DNA synthesis with a very dense semicondu... The Hyperion project will prove the concept of affordable, scalable data storage with DNA by developing a world beating writing technology based on the precise, robust control of enzymatic DNA synthesis with a very dense semiconductor integrated circuit. The 4-year research project will further develop a breakthrough approach by the deeptech research-intensive company DNA Script and show that very high-density enzymatic DNA synthesis is feasible. Furthermore, it will demonstrate proof of concept of high-density chip multiplexing, which will be essential to achieve performances commensurate with the best-in-class technologies (>terabyte capacity and MB/s writing speed). In the course of the Hyperion project, we will rely on fabrication and post-fabrication facilities located in the EU. This will contribute to the strengthening of capacity and expertise in line with the European Chips Act. Once the proof of principle is validated, the Hyperion approach will be the basis for deployable storage technologies that can eventually scale into the exabyte regime and beyond with reduced physical footprint, power and cost requirements relative to conventional storage technologies. This Hyperion project will contribute to the EIC Pathfinder Challenge goal by providing a writing solution fit to meet the future needs of a European DNA-based data storage industry. The impacts are expected to be immense on science, society, the environment, and the economy at large. ver más
31/08/2027
5M€
Duración del proyecto: 50 meses Fecha Inicio: 2023-06-19
Fecha Fin: 2027-08-31

Línea de financiación: concedida

El organismo HORIZON EUROPE notifico la concesión del proyecto el día 2023-06-19
Línea de financiación objetivo El proyecto se financió a través de la siguiente ayuda:
Presupuesto El presupuesto total del proyecto asciende a 5M€
Líder del proyecto
DNA SCRIPT SAS No se ha especificado una descripción o un objeto social para esta compañía.
Perfil tecnológico TRL 4-5